Fortress Biotech Inc Pref Series A
Biotechnology
Healthcare
FBIOP
29.82 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.20
52 week high
9.47
high
9.34
52 week low
0.00
low
9.01
growth
69.13 %
previous Close
9.25
P/E ratio
market cap
41.33 M
div yield
0
usd
Jun 2025
qoq
revenue
16.41 M
24.92 %
net incoming
15.49 M
246.32 %
eps
0.00 %
193.75 %
eps surprise
0.00 %
net profit margin
94.35 %
174.00 %
operating incoming
-36.47 M
-63.43 %
net change in cash
-16.95 M
-150.24 %
cash on hand
74.39 M
-18.56 %
cost of revenue
4.94 M
3.11 %
top top